Hous­ton start­up paus­es en­roll­ment in pe­di­atric can­cer tri­al af­ter pa­tient death

A small Hous­ton biotech is hit­ting the brakes on an ear­ly clin­i­cal tri­al af­ter a pa­tient’s death.

Salarius Phar­ma­ceu­ti­cals paused new pa­tient en­roll­ment in a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER